Objective: To determine whether supplementation with vitamin B 6 improves nausea and/or vomiting in pregnancy. Methods: This experimental study was conducted with 60 pregnant women experiencing nausea and/or vomiting prior to the 12th gestational week. Of these women, 30 were treated daily with 10 mg and the remaining 30 with 1.28 mg of pyridoxine hydrochloride for 2 weeks. The primary outcome was the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score in each group at the end of treatment. Results: The women experiencing nausea and/or vomiting in pregnancy had significantly lower levels of circulating vitamin B 6 (P = 0.007) compared with those without this symptom. Vitamin B 6 supplementation significantly increased plasma vitamin B 6 concentration (P < 0.05 in both groups). There were no significant differences in PUQE score or in plasma concentration levels of protein, dopamine, serotonin, unconjugated estriol, and ghrelin after supplementation between the 2 groups at baseline, but there was a significantly lesser decrease in PUQE score and a greater increase in vitamin B 6 level and vitamin B 6 concentration to plasma protein concentration ratios in group 1 than in group 2 after supplementation (P < 0.05 for all). Conclusion: Although the high-supplementation group had a greater decrease in PUQE score in comparison to the low-supplementation group, the difference is unlikely to affect the severity of symptoms. © 2011 International Federation of Gynecology and Obstetrics.

Vitamin B6 supplementation in pregnant women with nausea and vomiting.

FARINA, ANTONIO;
2012

Abstract

Objective: To determine whether supplementation with vitamin B 6 improves nausea and/or vomiting in pregnancy. Methods: This experimental study was conducted with 60 pregnant women experiencing nausea and/or vomiting prior to the 12th gestational week. Of these women, 30 were treated daily with 10 mg and the remaining 30 with 1.28 mg of pyridoxine hydrochloride for 2 weeks. The primary outcome was the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score in each group at the end of treatment. Results: The women experiencing nausea and/or vomiting in pregnancy had significantly lower levels of circulating vitamin B 6 (P = 0.007) compared with those without this symptom. Vitamin B 6 supplementation significantly increased plasma vitamin B 6 concentration (P < 0.05 in both groups). There were no significant differences in PUQE score or in plasma concentration levels of protein, dopamine, serotonin, unconjugated estriol, and ghrelin after supplementation between the 2 groups at baseline, but there was a significantly lesser decrease in PUQE score and a greater increase in vitamin B 6 level and vitamin B 6 concentration to plasma protein concentration ratios in group 1 than in group 2 after supplementation (P < 0.05 for all). Conclusion: Although the high-supplementation group had a greater decrease in PUQE score in comparison to the low-supplementation group, the difference is unlikely to affect the severity of symptoms. © 2011 International Federation of Gynecology and Obstetrics.
2012
Wibowo N; Purwosunu Y; Sekizawa A; Farina A; Tambunan V; Bardosono S.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/118052
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 21
social impact